December 27, 2022
Some things are never completely forgotten. Your first love, the overwhelming feeling of holding your first child in your arms — and certainly not your favorite […]
December 27, 2022
(Reuters) – An influential drug pricing research group said Eisai Co Ltd and Biogen Inc’s new Alzheimer’s disease treatment lecanemab should be priced lower than the […]
December 21, 2022
Women with cluster headache (CH) have more severe symptoms and longer headache bouts than men, and they are more likely to have a chronic subtype of […]
December 21, 2022
Need to motivate patients to power through tough workouts? Try telling them this: Those few moments of extra effort may help the brain stay sharp for […]
December 20, 2022
The number of US patients diagnosed with Parkinson’s disease (PD) each year is about 50% higher than previously thought, according to new research that investigators say […]
December 20, 2022
Combining two traditional Chinese therapies is better than just one for patients with chronic neck pain, new research suggests. In a randomized controlled study with more […]
December 19, 2022
NASHVILLE, Tennessee ― Scheduling video-electroencephalography (vEEG) monitoring on the basis of personalized seizure risk forecasts may improve diagnostic accuracy, emerging research suggests. In a validation study, […]
December 16, 2022
Use of spinal cord stimulation (SCM) is not associated with reduction in opioid use or nonpharmacologic pain intervention at 2 years, compared to conventional medical management […]
December 15, 2022
NASHVILLE, Tennessee ―The retention rate for the antiseizure drug perampanel (Eisai Co, Ltd) is more than 70% for adult patients with epilepsy, new research shows. In […]